{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T02:38:21Z","timestamp":1784255901617,"version":"3.55.0"},"reference-count":33,"publisher":"BMJ","issue":"10","license":[{"start":{"date-parts":[[2022,10,7]],"date-time":"2022-10-07T00:00:00Z","timestamp":1665100800000},"content-version":"unspecified","delay-in-days":6,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005036","name":"Universitetet i Bergen","doi-asserted-by":"publisher","award":["2019\/26961-ELRI"],"award-info":[{"award-number":["2019\/26961-ELRI"]}],"id":[{"id":"10.13039\/501100005036","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"published-print":{"date-parts":[[2022,10]]},"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>We have previously found that allergy is a risk factor for early-onset pre-eclampsia. The aim of this study was to assess the association between pregestational maternal use of antihistamines and early-onset pre-eclampsia.<\/jats:p><\/jats:sec><jats:sec><jats:title>Design<\/jats:title><jats:p>A population-based cohort study.<\/jats:p><\/jats:sec><jats:sec><jats:title>Setting and participants<\/jats:title><jats:p>All women giving birth in Norway 2004\u20132016, including 692 487 pregnancies. Data from the Medical Birth Registry of Norway were linked with data from the Norwegian Prescription Database. Prescriptions of antihistamines were divided into three groups: before pregnancy (&lt;6 months), early pregnancy (&lt;20 weeks) and late pregnancy (20\u201336 weeks). ORs with 95% CIs for pre-eclampsia &lt;34\u2009and &lt;37 weeks by antihistamine use were estimated by logistic regression and stratified on multiple pregnancy and parity. Predicted proportions (%) with 95% CIs were estimated.<\/jats:p><\/jats:sec><jats:sec><jats:title>Interventions<\/jats:title><jats:p>Use of antihistamines in relation to pregnancy in allergic women.<\/jats:p><\/jats:sec><jats:sec><jats:title>Main outcome measures<\/jats:title><jats:p>Development of early-onset pre-eclampsia.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>2997 (0.43%) and 5769 (0.83%) women had pre-eclampsia &lt;34\u2009and &lt;37 weeks, respectively. Use of antihistamines before and in early pregnancy was associated with a risk of developing early-onset pre-eclampsia that was comparable to the background population (OR 1.0, 95%\u2009CI 0.8 to 1.2 and OR 0.9, 95%\u2009CI 0.7 to 1.1, respectively). Antihistamine use only in late pregnancy was not treated as exposure, but as an indicator of allergy, and was associated with an increased risk of early-onset pre-eclampsia (OR 1.8, 95%\u2009CI 1.5 to 2.2). Predicted proportions of pre-eclampsia &lt;34 weeks were significantly lower in women using antihistamines before (0.41%, 95%\u2009CI 0.34 to 0.49) and in early pregnancy (0.37%, 95%\u2009CI 0.31 to 0.44), compared with women using antihistamines after placentation (0.69%, 95%\u2009CI 0.57 to 0.83). Results were similar for pre-eclampsia &lt;37 weeks.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Antihistamine use before or during placentation was associated with reduced risk of developing early-onset pre-eclampsia in allergic women compared with women using antihistamines after placentation.<\/jats:p><\/jats:sec>","DOI":"10.1136\/bmjopen-2022-061837","type":"journal-article","created":{"date-parts":[[2022,10,7]],"date-time":"2022-10-07T16:12:20Z","timestamp":1665159140000},"page":"e061837","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":7,"title":["Use of antihistamines before or during pregnancy and risk of early-onset pre-eclampsia in allergic women: a population-based cohort study"],"prefix":"10.1136","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8927-2253","authenticated-orcid":false,"given":"Anne K","family":"Sande","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik Andreas","family":"Torkildsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ragnar Kvie","family":"Sande","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingvild","family":"Dalen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1090-0590","authenticated-orcid":false,"given":"Kim Christian","family":"Danielsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nils-Halvdan","family":"Morken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2022,10,7]]},"reference":[{"key":"2022110108351632000_12.10.e061837.1","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jri.2018.04.004","article-title":"Maternal allergy as an isolated risk factor for early-onset preeclampsia: an epidemiological study","volume":"127","author":"Sande","year":"2018","journal-title":"J Reprod Immunol"},{"key":"2022110108351632000_12.10.e061837.2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01964898"},{"key":"2022110108351632000_12.10.e061837.3","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dmn014"},{"key":"2022110108351632000_12.10.e061837.4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jri.2006.04.002"},{"key":"2022110108351632000_12.10.e061837.5","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1111\/jog.13667","article-title":"How is the human umbilical artery regulated?","volume":"44","author":"Lorigo","year":"2018","journal-title":"J Obstet Gynaecol Res"},{"key":"2022110108351632000_12.10.e061837.6","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1152\/ajplegacy.1972.222.2.345","article-title":"Effects of vasoactive agents on isolated human umbilical arteries and veins","volume":"222","author":"Altura","year":"1972","journal-title":"Am J Physiol"},{"key":"2022110108351632000_12.10.e061837.7","first-page":"3","article-title":"Comparison of blood levels of histamine and total ascorbic acid in pre-eclampsia with normal pregnancy","volume":"38","author":"Sharma","year":"1984","journal-title":"Hum Nutr Clin Nutr"},{"key":"2022110108351632000_12.10.e061837.8","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)03577-7"},{"key":"2022110108351632000_12.10.e061837.9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jri.2019.07.004","article-title":"The two-stage placental model of preeclampsia: an update","volume":"134-135","author":"Staff","year":"2019","journal-title":"J Reprod Immunol"},{"key":"2022110108351632000_12.10.e061837.10","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1161\/HYPERTENSIONAHA.119.13722","article-title":"Why do circulating biomarkers predict early-onset preeclampsia, and can they also predict future maternal cardiovascular health?","volume":"74","author":"Staff","year":"2019","journal-title":"Hypertension"},{"key":"2022110108351632000_12.10.e061837.11","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1080\/10641955.2019.1640725","article-title":"Placental sFlt1 is associated with complement activation and syncytiotrophoblast damage in preeclampsia","volume":"38","author":"Yonekura Collier","year":"2019","journal-title":"Hypertens Pregnancy"},{"key":"2022110108351632000_12.10.e061837.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2013.08.019"},{"key":"2022110108351632000_12.10.e061837.13","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.3109\/14767058.2013.776533","article-title":"Comparison of clinical and laboratory findings in early- and late-onset preeclampsia","volume":"26","author":"Kucukgoz Gulec","year":"2013","journal-title":"J Matern Fetal Neonatal Med"},{"key":"2022110108351632000_12.10.e061837.14","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.117.10803"},{"key":"2022110108351632000_12.10.e061837.15","first-page":"CD004659","article-title":"Antiplatelet agents for preventing pre-eclampsia and its complications","author":"Duley","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"2022110108351632000_12.10.e061837.16","unstructured":"(NICE) NIfHaCE . Hypertension in pregnancy (QS35), 2013. Available: https:\/\/wwwniceorguk\/guidance\/qs35\/resources\/hypertension-in-pregnancy-pdf-2098607923141 [Accessed 07 May 2017]."},{"key":"2022110108351632000_12.10.e061837.17","unstructured":"(NICE) NIfHaCE . Hypetension in adults (QS28), 2013. Available: https:\/\/wwwniceorguk\/guidance\/qs28\/resources\/hypertension-in-adults-pdf-2098552495813 [Accessed 07 May 2017]."},{"key":"2022110108351632000_12.10.e061837.18","doi-asserted-by":"publisher","DOI":"10.1067\/mob.2000.107928"},{"key":"2022110108351632000_12.10.e061837.19","doi-asserted-by":"publisher","DOI":"10.1111\/aogs.12159"},{"key":"2022110108351632000_12.10.e061837.20"},{"key":"2022110108351632000_12.10.e061837.21","doi-asserted-by":"publisher","DOI":"10.1016\/0143-4004(95)90080-2"},{"key":"2022110108351632000_12.10.e061837.22","doi-asserted-by":"crossref","first-page":"S78","DOI":"10.1007\/s00011-004-0436-4","article-title":"Influence of histamine on the process of human trophoblast differentiation","volume":"54 Suppl 1","author":"Szewczyk","year":"2005","journal-title":"Inflamm Res"},{"key":"2022110108351632000_12.10.e061837.23","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/512926"},{"key":"2022110108351632000_12.10.e061837.24","first-page":"357","article-title":"Effects of histamine on vascular resistance and protein permeability in the isolated dually perfused guinea-pig placenta","volume":"10","author":"Berhe","year":"1988","journal-title":"J Dev Physiol"},{"key":"2022110108351632000_12.10.e061837.25","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinbiochem.2016.12.011"},{"key":"2022110108351632000_12.10.e061837.26","doi-asserted-by":"crossref","first-page":"S53","DOI":"10.1007\/s00011-006-0526-6","article-title":"Luminometric determination of amine oxidase activity","volume":"56 Suppl 1","author":"Schwelberger","year":"2007","journal-title":"Inflamm Res"},{"key":"2022110108351632000_12.10.e061837.27","doi-asserted-by":"crossref","unstructured":"Velicky P , Windsperger K , Petroczi K , et al . Pregnancy-Associated diamine oxidase originates from extravillous trophoblasts and is decreased in early-onset preeclampsia. Sci Rep 2018;8:6342.doi:10.1038\/s41598-018-24652-0","DOI":"10.1038\/s41598-018-24652-0"},{"key":"2022110108351632000_12.10.e061837.28","unstructured":"Fernandes MB , Guerra J . O Amplictil-Phenergan no trattamento dA eclampsia:15\u201322."},{"key":"2022110108351632000_12.10.e061837.29","first-page":"1458","article-title":"\u00dcber die Wirkung einer neuen Thipendyl-Verbindung in Der Geburtshilfe","volume":"37","author":"Sch\u00f6nherr","year":"1958","journal-title":"Medizinische"},{"key":"2022110108351632000_12.10.e061837.30","doi-asserted-by":"crossref","first-page":"2848","DOI":"10.1111\/bcp.14117","article-title":"Maternal use of drugs and preeclampsia","volume":"85","author":"Sahlman","year":"2019","journal-title":"Br J Clin Pharmacol"},{"key":"2022110108351632000_12.10.e061837.31","unstructured":"Olsen K . Reseptfrie legemiddel selt I b\u00e5de daglegvare OG apotek I 2019, 2020. Available: https:\/\/www.fhi.no\/hn\/legemiddelbruk\/omsetning-utenom-apotek\/Reseptfrie-legemiddel-selt-i-baade-daglegvare-og-apotek-i-2019\/"},{"key":"2022110108351632000_12.10.e061837.32","unstructured":"Granum BB NW , Nygaard UC . Astma OG allergi (asthma and allergy). Norwegian National Institute of public health, 2014."},{"key":"2022110108351632000_12.10.e061837.33","unstructured":"Health TNIoP . F\u00f8dselsstatistikk for 2014. Norwegian Institute of Public Health, 2015."}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2022-061837","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T15:36:25Z","timestamp":1667316985000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2022-061837"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":33,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2022,10,7]]},"published-print":{"date-parts":[[2022,10]]}},"alternative-id":["10.1136\/bmjopen-2022-061837"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2022-061837","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10]]}}}